Orient EuroPharma Co., Ltd. (TPEX:4120)
Taiwan · Delayed Price · Currency is TWD 46.00
0.00 (0.00%)
Sep 8, 2026, 1:30 PM CST
Orient EuroPharma Market Cap
Orient EuroPharma has a market cap or net worth of 3.99 billion as of September 8, 2026. Its market cap has decreased by -14.81% in one year.
Market Cap
3.99B
Enterprise Value
6.98B
Revenue
4.65B
Ranking
n/a
PE Ratio
n/a
Stock Price
46.00
ChartMarket Cap Chart
Since November 3, 2004, Orient EuroPharma's market cap has increased from 700.81M to 3.99B, an increase of 469.39%. That is a compound annual growth rate of 8.28%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2026 | 3.99B | 2.68% |
| Dec 31, 2025 | 3.89B | -7.05% |
| Dec 31, 2024 | 4.18B | 23.91% |
| Dec 29, 2023 | 3.37B | 7.46% |
| Dec 30, 2022 | 3.14B | -0.41% |
| Dec 30, 2021 | 3.15B | -24.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| SCI Pharmtech | 6.43B |
| Alar Pharmaceuticals | 6.28B |
| Orient Pharma | 6.11B |
| Formosa Laboratories | 5.48B |
| Panion & Bf Biotech | 4.84B |
| LIWANLI Innovation | 4.66B |
| Yoda Pharmaceuticals | 4.61B |
| Easywell Biomedicals | 3.73B |